NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 121 filers reported holding NURIX THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,262,000 | +2.8% | 327,123 | 0.0% | 11.14% | -1.1% |
| Q2 2022 | $4,145,000 | -9.6% | 327,123 | 0.0% | 11.26% | +10.7% |
| Q1 2022 | $4,583,000 | -51.6% | 327,123 | 0.0% | 10.17% | -40.9% |
| Q4 2021 | $9,470,000 | -43.7% | 327,123 | -41.7% | 17.20% | -31.0% |
| Q3 2021 | $16,825,000 | -7.6% | 561,574 | -18.2% | 24.93% | +69.0% |
| Q2 2021 | $18,207,000 | -14.7% | 686,274 | 0.0% | 14.76% | -9.7% |
| Q1 2021 | $21,336,000 | -5.4% | 686,274 | 0.0% | 16.34% | -0.6% |
| Q4 2020 | $22,565,000 | – | 686,274 | – | 16.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 4,508,333 | $140,164,000 | 17.73% |
| Ponoi II Management, LLC | 686,274 | $21,336,000 | 16.34% |
| Column Group LLC | 5,383,333 | $167,368,000 | 16.04% |
| Ponoi Management, LLC | 686,274 | $21,336,000 | 12.55% |
| Foresite Capital Management IV, LLC | 1,238,456 | $38,504,000 | 4.61% |
| Foresite Capital Management V, LLC | 451,522 | $14,038,000 | 4.13% |
| WestHill Financial Advisors, Inc. | 283,333 | $8,809,000 | 3.13% |
| EcoR1 Capital, LLC | 2,019,019 | $62,771,000 | 2.78% |
| Bain Capital Life Sciences Investors, LLC | 1,284,314 | $39,929,000 | 2.26% |
| DAFNA Capital Management LLC | 306,320 | $9,523,000 | 2.26% |